URI:
   DIR Return Create A Forum - Home
       ---------------------------------------------------------
       funpics
  HTML https://funpics.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: Health self-help 
       *****************************************************
       #Post#: 2459--------------------------------------------------
       Viagr.a reloaded
   DIR By: lubhan
       Date: December 16, 2016, 4:19 am
       ---------------------------------------------------------
       A chance discovery a decade ago led to happy men all over the
       world. But two years after the official launch in India, ****
       continues to battle local variants that offer the same benefits
       at a fraction of the cost, due to a glitch in the patent
       process.
       Some of the world’s most amazing scientific inventions or rather
       discoveries seem to have come about through happenstance. Sir
       Alexander Fleming chanced upon penicillin while studying
       Staphylococcus. Similarly, Constantin Fahlberg, a chemist
       working on coal tar derivates produced the world’s first
       artificial sweetener – saccharin (accidentally of course). And
       then there’s the legendary tale of how a drug, initially
       engineered to combat angina became the saviour of men across the
       world, woe struck by an altogether different ailment – erectile
       dysfunction. Sildenafil citrate, commonly known as **** - the
       wonder cure disguised as a little blue pill, which became a part
       of pop culture lexicon, acknowledged by the likes of rap star
       Eminem and football legend Pele, and also a cause of heartburn
       for millions of netizens buckling under the weight of **** spam
       mails, celebrates its tenth birthday this year.
       Never in the history of mankind has a drug gained the sort of
       instant recall value that **** has. And there are good reasons
       for this too. According to the spokesperson from Pfizer,
       "Erectile dysfunction affects approximately 50 per cent of men
       over the age of 40 in varying degrees of severity." So it seems
       only inevitable that a panacea to this ailment would be picked
       off the shelves like hot cakes.
       The Pfizer spokesperson says, "Since the year 1998, it is
       estimated that over 1.8 billion **** pills have been dispensed
       to more than 35 million men in more than 120 countries around
       the world. And today, **** is known to be the most prescribed
       oral treatment for erectile dysfunction."
       However, with respect to India, it’s just been a little over two
       years since **** was officially launched in the local markets.
       **** arrived in India in December 2005 and was priced at a hefty
       Rs 463 for a 50 mg tablet and Rs 594 for a 100 mg tablet. Of
       course, that hasn’t prevented variants like Penagra and Caverta
       (which also contain the chemical Sildenafil citrate and are
       prescribed as drugs to treat erectile dysfunction) to establish
       grounds in India. Priced at a fraction of what the real ****
       costs, these drugs comprise a big portion of what makes the
       market for ED drugs in India. According to sales audit data
       released by IMSP, the market for erectile dysfunction drugs in
       India as of Feb 2008 stands at Rs 134.04 crores (recorded over a
       12-month period). The figure is a potent reminder of the size of
       the market for such drugs in India. But despite Pfizer’s almost
       complete control over the patent of ****, a clause in the
       Intellectual Property Rights Act allowed companies to
       independently manufacture the drug in India, albeit with a
       slight modification.
       A highly placed source in the pharmaceutical industry explains
       this saying, "Until the year 2005, India followed a process
       patent and not a product patent. As this was the case, companies
       other than Pfizer found this as window of opportunity to launch
       their products in India." So are the variants anywhere as good
       as the real thing? Dr D. Narayana Reddy, an eminent sexologist
       says, "The variants of **** can serve the same purpose as ****
       does. However, with regards to the chemical Sildenafil citrate,
       some patients are known to complain of blurred or blue tinted
       vision and side effects of other kinds."
       Dr Reddy says, "One of the biggest achievements of this drug is
       that it brought sex out of the bedrooms and into the living
       rooms. Before ****, people had the opinion that sexual medicine
       was an unnecessary luxury. Thanks to the unprecedented media
       publicity given to the drug, even the medical fraternity was
       shaken out of its slumber and sexual disorders were recognised
       as a valid and important issue to be addressed and worked upon."
       He adds, "In fact, **** happened to be the one reason why
       pharmaceutical companies started pumping money for researching
       sexual problems."
       However, the arrival of cheaper alternatives has also spawned a
       growth of spurious manufacturers who tried to cash in on the
       **** name.
       The Internet is overloaded with ads for everything from herbal
       Viagras to traditional oriental alternatives that are priced at
       almost a tenth of the real ****. Erectile dysfunction drugs fall
       under the category of Schedule H drugs, which means that you
       need to have a doctor’s prescription to buy them.
       But nowadays, anybody can walk into a drugstore and get even
       such medicines without a prescription. A spokesperson from the
       pharmaceutical industry says, "The manufacturers themselves
       govern the demand and supply for these drugs in many cases. For
       instance, when a certain Indian alternative to **** was launched
       in 2003, the pharmaceutical company offered its retailers
       unbelievably high amounts of cash discounts in order to stock
       excess quantities of the same, thereby creating a surplus of
       their product in the market."
       **** in motion
       * In February last year, doctors in England used **** to save
       the life of a premature baby, which was all of 24 weeks old and
       weighed 780 gram. Owing to the failure of one of its lungs, the
       baby wasn’t able to get enough oxygen in his bloodstream. But
       upon being administered the drug, the tiny blood vessels in its
       lungs opened up, which allowed oxygen to be pumped into all
       parts of his body.
       * **** is known to be an antidote for rare pulmonary
       hypertension (PH), which can lead to chronic high blood
       pressure. A two-year old child in England named Oliver Sherwood
       is administered with a dosage of **** on a daily basis – just so
       that he can stay alive. Although the drug is expensive, his
       mother remarks that it’s actually the cheapest way to treat PH.
       Top Internet **** Jokes
       What do **** and Disney World have in common?
       A one-hour wait for a two-minute ride.
       What is the difference between your first honeymoon and your
       second?
       The first: Niagara; the second: ****.
       Did you hear about the first death from an overdose of ****?
       A man took twelve pills and his wife died.
       *****************************************************
       Page 1 of 1